The COVID-19 pandemic has forced all of us to change priorities and perspectives. The reaction of the scientific community has been focused, fast and incredibly effective. It is difficult to recall in the history of mankind such a cohesion of intents and efforts among countries in defeating a new threat to humanity. We have learned that joining forces is the winning strategy against any threat, cancer included. However, SARS-Cov-2 only partially distracted the basic, translational and clinical research in cancer.

Inspired by this overwhelming experience and eager to share the last groundbreaking discoveries in cancer immunology and immunotherapy with the scientific community and for the benefit of cancer patients, the Italian Network for the Biotherapy of Cancer (NIBT) is proud to announce the XIX NIBIT Meeting 2021, whose main theme will be “Cancer immunity and immunotherapy beyond the COVID-19.”

The meeting will roll out in the web on October 14-15, 2021, and it will gather top clinicians and scientists to discuss about novel concepts in cancer immunology such as trained immunity, cancer & immune metabolism, and virus-based therapeutic platforms in the intersection between cancer and COVID-19. We will also have updates on cutting-hedge therapies in hematologic malignancies and solid tumors like melanoma, lung, breast, prostate, head and neck and several others. Each session will host a 20’ open discussion animated by experts in the field. There will be plenty of space for oral communications from the audience of the youngest investigators.